🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Exciting new data on the effects of SGLT2-inhibitors on sodium and glucose handling in patients with acute heart failure in a study by Boorsma et al, published in the European Journal of Heart Failure. Read more about it on our website: groningencardiology.com/publication-ef…

Additionally, empagliflozin increased plasma osmolality without affecting urinary osmolality. There was an early ⬇️ in #eGFR with empagliflozin compared to placebo which recovered within 30 days ✔️

Our data suggests that ✅ empagliflozin stimulates osmotic diuresis through increased glucosuria rather than natriuresis in acute HF patients. The intrigue of #SGLT2i continues, demonstrating suitability as an add-on therapy to diuretics in acute HF ✨

Save the date! The Young@Heart spring Event of 2022 with the topic 'Integrity in Science' will be on the 3rd of June in Utrecht! #CardioTwitter #PhD Dutch CardioVascular Alliance Hartstichting